Gemlieva 1000 mg

Gemlieva 1gm Injection is a chemotherapy drug that contains gemcitabine as its active ingredient. It is utilized in the treatment of various cancers, including bladder, breast, ovarian, pancreatic, and non-small cell lung cancers. Cancer is characterized by the uncontrolled and abnormal proliferation of cells. Consult your physician if you have a history of heart disease, liver issues, kidney problems, have recently undergone radiotherapy, or have been vaccinated prior to using this medication.

Gemlieva 1gm Injection is not advised for individuals under 18 years of age, including adolescents and children. Your healthcare provider will monitor your blood cell counts as well as your kidney and liver functions each time you receive this treatment. It is essential to use effective contraception during the course of treatment and for at least six months following the final dose. This injection may affect male fertility, and men receiving this medication are cautioned against fathering a child during treatment and for six months afterward.

Inform your doctor if you are following a salt-restricted diet, as this medication contains sodium. If you experience symptoms such as shortness of breath, wheezing, changes in urine color or volume, bleeding, or upper abdominal pain while receiving Gemlieva 1gm Injection, contact your physician immediately.